RGEN

Repligen Corporation

195.87 USD
+1.88 (+0.97%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Repligen Corporation stock is up 3.42% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.88% of the previous 34 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Feb 15:53 16 Feb, 2024 155.00 CALL 5 11
21 Feb 16:11 21 Jun, 2024 195.00 PUT 19 1
29 Feb 15:17 17 May, 2024 230.00 CALL 150 216
29 Feb 15:17 17 May, 2024 230.00 CALL 217 216
29 Feb 15:19 17 May, 2024 230.00 CALL 1515 216
01 Mar 17:13 16 Aug, 2024 260.00 CALL 127 1
01 Mar 17:13 16 Aug, 2024 260.00 CALL 317 1
01 Mar 17:19 16 Aug, 2024 260.00 CALL 100 1
01 Mar 17:19 16 Aug, 2024 260.00 CALL 100 1
01 Mar 17:20 16 Aug, 2024 260.00 CALL 1100 1

About Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company sells its products to life sciences, biopharmaceutical companies; laboratory researchers; and contract manufacturing organizations.

  • Stifel
    Thu Feb 22, 14:03
    buy
    confirm
  • Keybanc
    Thu Feb 15, 14:12
    buy
    confirm